DRIVE (Development of Robust and Innovative Vaccines Effectiveness) is a public private partnership that aims to advance European cooperation in influenza vaccine effectiveness studies. Its partners include public health institutions, universities, small and medium-sized enterprises, vaccine manufacturers, and patient organizations.
DRIVE was formed in July 2017 and aims to establish a sufficiently sized network to generate robust, high quality, brand-specific effectiveness estimates for all influenza vaccines used in the EU each season. The data generated through DRIVE is expected to increase the understanding of influenza vaccine effectiveness, lead to enhanced monitoring of influenza vaccine performance by public health institutes and allow manufacturers to fulfil the requirements of the European Medicines Agency (EMA).
DRIVE also aims to develop a sustainable and transparent governance model for public private partnerships.